These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18984533)

  • 1. Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern.
    Evain S; Briec F; Kyndt F; Schott JJ; Lande G; Albuisson J; Abbey S; Le Marec H; Probst V
    Heart Rhythm; 2008 Nov; 5(11):1561-4. PubMed ID: 18984533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).
    Nishizaki M; Sakurada H; Yamawake N; Ueda-Tatsumoto A; Hiraoka M
    Circ J; 2010 Nov; 74(11):2464-73. PubMed ID: 20962431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
    Shimizu A
    Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
    Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of fever-induced Brugada syndrome.
    Mizusawa Y; Morita H; Adler A; Havakuk O; Thollet A; Maury P; Wang DW; Hong K; Gandjbakhch E; Sacher F; Hu D; Amin AS; Lahrouchi N; Tan HL; Antzelevitch C; Probst V; Viskin S; Wilde AA
    Heart Rhythm; 2016 Jul; 13(7):1515-20. PubMed ID: 27033637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk stratification in Brugada syndrome].
    Delise P; Allocca G; Marras E; Sitta N; Corò L; Berton G
    G Ital Cardiol (Rome); 2011 Jun; 12(6):400-7. PubMed ID: 21691376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.
    Kamakura S; Ohe T; Nakazawa K; Aizawa Y; Shimizu A; Horie M; Ogawa S; Okumura K; Tsuchihashi K; Sugi K; Makita N; Hagiwara N; Inoue H; Atarashi H; Aihara N; Shimizu W; Kurita T; Suyama K; Noda T; Satomi K; Okamura H; Tomoike H;
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):495-503. PubMed ID: 19843917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
    Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
    Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
    Mizobuchi M; Enjoji Y; Nakamura S; Muranishi H; Utsunomiya M; Funatsu A; Kobayashi T
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):266-73. PubMed ID: 19954504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brugada syndrome: diagnosis and risk stratification].
    Delise P; Allocca G; Marras E; Sitta N; Sciarra L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):107S-113S. PubMed ID: 21416838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syncope and intermittent Brugada ECG pattern.
    Cordeiro Piçarra B; Silva Cunha P; Oliveira M; Valente B; Nogueira da Silva M; Santos S; Cruz Ferreira R
    Rev Port Cardiol; 2013 May; 32(5):411-4. PubMed ID: 23623363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome.
    Letsas KP; Efremidis M; Weber R; Korantzopoulos P; Protonotarios N; Prappa E; Kounas SP; Evagelidou EN; Xydonas S; Kalusche D; Sideris A; Arentz T
    Heart Rhythm; 2011 Jun; 8(6):874-8. PubMed ID: 21315837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brugada syndrome in Canada: a unique French-Canadian experience.
    Champagne J; Philippon F; Gilbert M; Molin F; Blier L; Nault I; Sarrazin JF; Charbonneau L; Dufort L; Drolet B; Chahine M; O'Hara GE
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):71B-75B. PubMed ID: 17932591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome.
    Take Y; Morita H; Wu J; Nagase S; Morita S; Toh N; Nishii N; Nakamura K; Kusano KF; Ohe T; Ito H; Zipes DP
    Heart Rhythm; 2011 Jul; 8(7):1014-21. PubMed ID: 21315838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis.
    Sieira J; Ciconte G; Conte G; Chierchia GB; de Asmundis C; Baltogiannis G; Di Giovanni G; Saitoh Y; Irfan G; Casado-Arroyo R; Julià J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1144-50. PubMed ID: 26215662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging.
    Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R
    Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.